(2'R,7R,8R,10S,13S,14S)-Methyl 10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,10,12,13,14,15,16-tetradecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-carboxylate(CAS: 95716-70-4)

This compound crystallizes as a white solid with a high melting point. Its molecular weight is approximately 521.5 g/mol. It is slightly soluble in common organic solvents like dichloromethane and acetone. Chemically, it is reactive towards nucleophiles and can undergo ester hydrolysis under acidic conditions. It has a low reactivity towards electrophiles, making it stable in most organic reactions.

This compound is typically synthesized via an esterification reaction of a suitable alcohol with a carboxylic acid, followed by ring closure to form the spiro structure. Commonly, this is achieved using a Lewis acid catalyst like aluminum chloride or titanium(IV) isopropoxide. The reaction requires precise control of temperature and solvent to achieve high selectivity and yield.

This compound is most commonly used in the pharmaceutical industry for its structural complexity, potentially providing unique biological activities. It is also explored in the polymer industry for its potential to form novel materials with specific properties. Additionally, it may be used in the development of sensors and other advanced materials due to its unique molecular architecture.

When handling this compound, it is essential to wear appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. Work should be conducted in a well-ventilated area, preferably under a fume hood, to minimize inhalation risks. In case of a spill, immediately contain it with absorbent material and clean up according to the Material Safety Data Sheet (MSDS) guidelines. Always consult the SDS for specific safety information and emergency protocols.